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ABSTRACT 
Background: Warfarin dosing after bariatric surgery may be influenced by alterations in 
gastrointestinal pH, transit time, absorptive surface area, gut microbiota, food intake, and 
adipose tissue. 
Objectives: The aim of this study was to describe trends in warfarin dosing after Roux-en-Y 
gastric bypass (RYGB) and sleeve gastrectomy (SG). 
Setting: Single academic center. 
Methods: All patients chronically on warfarin anticoagulation before RYGB or SG were 
retrospectively identified. Indications for anticoagulation, history of bleeding or thrombotic 
events, perioperative complications, and warfarin dosing were collected. 
Results: Fifty-three patients (RYGB n = 31, SG n = 22) on chronic warfarin therapy were 
identified (56.6% female, mean 54.4 ± 11.7 yr of age). Of this cohort, 34.0% had prior venous 
thromboembolic events, 43.4% had atrial fibrillation, and 5.7% had mechanical cardiac valves. 
Preoperatively, the average daily dose of warfarin was similar in the RYGB group (8.3 ± 4.1 
mg) and SG group (6.9 ± 2.8 mg). One month after surgery, mean daily dose of warfarin was 
reduced 24.1% in the RYGB group (P<.001) and 23.2% in the SG group (P = .002). At 12 
months postoperatively, the required daily warfarin dose compared with baseline remained 
statistically different (RYGB: 6.8 ± 3.8 mg; SG: 6.1 ± 2.0 mg). 
Conclusions: The warfarin dose is expected to be decreased by approximately 25% from 
preoperative levels after both RYGB and SG. Lower dose requirement within the first month 
after bariatric surgery is followed by a trend toward increased warfarin dose requirements, but 
remain less than baseline. Because dose requirements change constantly over time, frequent 
postoperative monitoring of the international normalized ratio is recommended. 
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